search

The latest Jewish News

Read this week’s digital edition

Click Here
More issues
Pfizer
CytoReason founder David Harel
November 22, 2022, 1:36 pm
Israeli start-up secured a deal with Pfizer just a year after launch
David Harel, founder of CytoReason, tells the tale of every entrepreneur's dream
By Candice Krieger
President of Israel Isaac Herzog, Founder and Chairman of The Genesis Prize Foundation Stan Polovets, and 2022 Genesis Prize Laureate, Dr. Albert Bourla. Photography credit: Lior Mizrahi, Getty
June 30, 2022, 12:22 pm
Pfizer boss receives Genesis Prize in Jerusalem
The annual $1 million Genesis Prize, dubbed the "Jewish Nobel", honours extraordinary individuals for their outstanding , contribution to humanity.
By JN Reporter
Pfizer's Albert Bourla, the 2022 Genesis Prize recipient (Photo: Joshua Jordan)
January 20, 2022, 9:38 am
Pfizer executive Albert Bourla named winner of 2022 ‘Jewish Nobel’
The Genesis Prize was awarded for his role in delivering a COVID-19 vaccine ‘in record time’
By Jewish News Reporter
A nurse holds a phial containing the Pfizer-BioNTech Covid-19.
November 15, 2021, 3:37 pm
Israel to buy tens of thousands of doses of Pfizer’s anti-COVID pill
The pharmaceutical company says the pill slashes the risk of hospitalisation or death from the virus by 89%.
By JTA
A nurse holds a phial containing the Pfizer-BioNTech Covid-19.
July 1, 2021, 11:06 am
Israel and UK ‘in talks’ over COVID-19 vaccine swap
The deal would see Britain accept one million Pfizer doses that are due to expire at the end of July
By Michael Daventry
Israeli PM with a delivery of Covid vaccines
March 18, 2021, 3:19 pm
Pfizer boss praises Netanyahu’s ‘obsessive’ drive to secure vaccine deal
Albert Bourla said Bibi 'convinced me that Israel is the place with the right conditions' after the prime minister called him 30 times
A medical worker prepares a vaccine against the COVID-19 at a municipality vaccine center in Tel Aviv, Israel, Dec. 31, 2020. (Gideon Markowicz/JINI via Xinhua)
January 20, 2021, 4:36 pm
Israeli data throws UK vaccine plans off course
Fears over second dose delay after study of 200,000 people showed only 33 percent efficacy after the first dose, compared to the 89 percent claimed by the UK
By Stephen Oryszczuk
A volunteer participates in a clinical trial for its COVID-19 vaccine candidate (Photo: PA/Business Wire)
November 14, 2020, 6:08 pm
Israel signs Covid vaccine deal to acquire eight million doses
Move comes days after Prime Minister Benjamin Netanyahu referenced Pfizer's CEO, Albert Bourla, being proud of his Jewish heritage
By JTA
Pfizer CEO Albert Bourla, right, is juxtaposed with Josef Mengele on the front page of the Makeleio daily in Greece, Nov. 10, 2020. (Courtesy of the Central Board of Jewish Communities in Greece via JTA)
November 13, 2020, 10:28 am
Greek newspaper likens Pfizer’s Jewish CEO to Josef Mengele on its front-page
Makeleio daily, which was recently convicted of antisemitic defamation, depicted infamous Nazi war criminal Dr. Josef Mengele alongside Jewish pharmaceutical CEO Albert Bourla
By JTA
El Al plane
August 29, 2019, 11:44 am
Tel Aviv-Dublin direct flight to be launched in May 2020
New route linking two major tech hubs in Ireland and Israel will be introduced by El Al airline next year
By Jewish News Reporter
University College Cork
April 3, 2017, 9:40 am
Financial backers of Cork Uni conference on Israel urged to pull funding
Jewish activists condemn a 'festival of Jew hate' in Ireland, and urge financial backers to pull support for the event
Load More